|
|
|
|
Дата |
|---|
| 07.04.2026 |
| 02.04.2026 |
| 01.04.2026 |
| 31.03.2026 |
| 30.03.2026 |
| 27.03.2026 |
| 26.03.2026 |
| 25.03.2026 |
| 24.03.2026 |
| 23.03.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
222.00
|
218.00
|
224.00
|
218.00
|
|
|
794 963.75
|
|
|
|
|
224.50
|
218.00
|
226.50
|
222.00
|
|
|
1 819 320.75
|
|
|
|
|
226.00
|
221.50
|
227.50
|
224.50
|
|
|
1 702 854.00
|
|
|
|
|
220.00
|
220.00
|
225.50
|
225.00
|
|
|
2 295 836.50
|
|
|
|
|
219.00
|
217.50
|
221.00
|
221.00
|
|
|
2 087 631.00
|
|
|
|
|
219.00
|
218.00
|
220.50
|
219.00
|
|
|
1 939 846.50
|
|
|
|
|
215.00
|
215.00
|
221.00
|
218.50
|
|
|
2 712 566.00
|
|
|
|
|
210.00
|
210.00
|
215.00
|
212.50
|
|
|
1 696 679.00
|
|
|
|
|
206.00
|
203.50
|
208.50
|
208.50
|
|
|
2 151 791.00
|
|
|
|
|
205.00
|
199.00
|
208.00
|
204.00
|
|
|
1 800 612.25
|
|
Период |
|---|
| 2024, регулярные |
| 2023, регулярные |
| 2022, регулярные |
| 2021, регулярные |
| 2021, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2018, регулярные |
| 2017, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
02.07.2025
|
03.07.2025 |
4.9 CHF |
|
07.08.2024
|
08.08.2024 |
7.5 CHF |
|
03.08.2023
|
04.08.2023 |
7.5 CHF |
|
30.08.2022
|
31.08.2022 |
9.7 CHF |
|
07.09.2021
|
08.09.2021 |
12.5 CHF |
|
08.09.2020
|
09.09.2020 |
7.7 CHF |
|
10.09.2019
|
11.09.2019 |
7.5 CHF |
|
19.09.2018
|
20.09.2018 |
1.5 CHF |
|
27.06.2018
|
28.06.2018 |
5.5 CHF |
|
28.06.2017
|
29.06.2017 |
5.8 CHF |
HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of some twenty five promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).
